An international survey of physician and patient understanding, perception, and attitudes to atrial fibrillation and its contribution to cardiovascular disease morbidity and mortality. - Wikidata - wikimedia - TriplyDB

An international survey of physician and patient understanding, perception, and attitudes to atrial fibrillation and its contribution to cardiovascular disease morbidity and mortality.

An international survey of physician and patient understanding, perception, and attitudes to atrial fibrillation and its contribution to cardiovascular disease morbidity and mortality.

http://www.wikidata.org/entity/Q33811339

about

Identifying postoperative atrial fibrillation in cardiac surgical patients posthospital discharge, using iPhone ECG: a study protocol.Hemoglobin A1c and risk of left atrial thrombus and spontaneous echo contrast in non-valvular atrial fibrillation patients Patient perspective on the management of atrial fibrillation in five European countries.Addressing barriers to optimal oral anticoagulation use and persistence among patients with atrial fibrillation: Proceedings, Washington, DC, December 3-4, 2012 Stroke Prevention in Atrial Fibrillation: Where are We Now?Atrial fibrillation: its prevalence and risk factor profile in the German general population.Screening Education And Recognition in Community pHarmacies of Atrial Fibrillation to prevent stroke in an ambulant population aged >=65 years (SEARCH-AF stroke prevention study): a cross-sectional study protocol Stroke prevention in atrial fibrillation: concepts and controversies Reproducibility and Reliability of the Quality of Life Questionnaire in Patients With Atrial Fibrillation.Patient preferences at ten years following initial diagnosis of atrial fibrillation: the Belgrade Atrial Fibrillation Study.Demographic Characteristics and Patterns of Medication in Atrial Fibrillation Patients in South West Ontario: Insights from a Large Primary Care Database.Bleeding risk assessment and management in atrial fibrillation patients: a position document from the European Heart Rhythm Association, endorsed by the European Society of Cardiology Working Group on Thrombosis.Is bleeding a necessary evil? The inherent risk of antithrombotic pharmacotherapy used for stroke prevention in atrial fibrillation.Disease understanding in patients newly diagnosed with atrial fibrillation.Choosing the right drug to fit the patient when selecting oral anticoagulation for stroke prevention in atrial fibrillation.Factors Affecting Patients' Perception On, and Adherence To, Anticoagulant Therapy: Anticipating the Role of Direct Oral Anticoagulants.'What else can I do?': Insights from atrial fibrillation patient communication online.Predictive factors for obtaining a correct therapeutic range using antivitamin K anticoagulants: a tertiary center experience of patient adherence to anticoagulant therapy.How are patients with atrial fibrillation approached and informed about their risk profile and available therapies in Europe? Results of the European Heart Rhythm Association Survey.Health Literacy and Atrial Fibrillation: Relevance and Future Directions for Patient-centred Care.Association between subjective risk perception and objective risk estimation in patients with atrial fibrillation: a cross-sectional study.Building Atrial Fibrillation Awareness: Is it Time to get Beyond the Top Line?Patients' experiences from symptom onset to initial treatment for atrial fibrillation.A proposal for interdisciplinary, nurse-coordinated atrial fibrillation expert programmes as a way to structure daily practice.Content and distribution of discursive space in consultations between patients with atrial fibrillation and healthcare professionals.Are Older Adults Willing to Consider New Strategies to Reduce Stroke Risk?Oral anticoagulation in patients with atrial fibrillation and medical non-neoplastic disease in a terminal stage.Perception paradox between the doctors and patients in the industrial-bureaucratic age of medicine: Defensive versus offensive medicine in anticoagulation and atrial fibrillation ablation.Oral Anticoagulation in Atrial Fibrillation: Development and Evaluation of a Mobile Health Application to Support Shared Decision-Making.Patients' experiences of communication and involvement in decision-making about atrial fibrillation treatment in consultations with nurses and physicians.Knowledge of Atrial Fibrillation and Stroke Prevention: Development of Questionnaire and Validation of Results.

P2860

Q30616300-525CCEAE-422F-4FC4-8053-D907635CE834 Q33592535-E92A3768-3DAD-40DE-8D2C-B6428E2C2D6D Q34448536-015E8C15-6C98-4C39-9138-18DEE88EA3EB Q34725585-1BD2BF63-C5D0-4FD2-ACE9-5B11966BD3CA Q35811581-C2EA5E1C-DEA7-48ED-9D7D-670CA29ED7C3 Q35949669-91DE4974-3FE7-4823-A171-351C6F40C348 Q36060854-B55A720D-80B9-4C41-B728-28D9A640E952 Q36382375-380067E1-69F4-4651-B19F-4FC44838414B Q36738217-73CA89C3-5B72-4F21-827B-B4483397E405 Q37134738-6960C898-B014-4609-934E-CC6752EC1186 Q37496201-DA803C5E-4291-4114-92B6-8BBB450FB4EC Q37868373-79494585-AFED-4094-A06C-9D3FCCD0164E Q38132255-84BB537A-8450-497E-BBB9-452DC19ABA10 Q38372509-06C131F5-7479-4E62-B987-7D4086D72728 Q38372780-5549E981-170A-4B9C-8448-9693910495E3 Q38903357-099BD60E-68BC-496C-9775-E26B792A4A50 Q38940342-E571A735-6276-4CA9-82DB-A67478BB9DCF Q40520350-902333E3-99DF-4BCA-8B94-34CCC305E2C5 Q41342570-A9C76146-AC2E-4BEB-85FA-E61DCA088AA2 Q41720527-767281E1-2320-4789-A4F5-21892A4CD56F Q42110922-5532D60A-48C8-43A0-AD6A-6D37BD22CDDF Q42353692-BB7F6900-EED9-4AE1-A683-8D1DD55FA094 Q42694656-62AAF548-ABC3-4EBD-9BD8-4CA28C833497 Q43449633-12DF66CD-E312-4B35-9039-D33C749A80B7 Q45913748-ABDABB2A-7D6D-423B-82AB-A4A8A3EB443D Q47911720-AE4D1BB9-0C03-4F7D-8064-59E9847F6429 Q48116623-88DBF987-A9E4-486E-B141-6C5A6966A54B Q48353520-A61A0EA7-462D-4BFB-9D5A-D691885ECE05 Q50142620-16361B48-8ECB-43FF-BBCE-E76742BC0ECB Q50247484-BAF9BE33-6FF6-4665-9B87-D1F23598E680 Q55276537-D92CE748-17D1-4CB5-B05D-DF2E2EC76235

P2860

An international survey of physician and patient understanding, perception, and attitudes to atrial fibrillation and its contribution to cardiovascular disease morbidity and mortality.

http://www.wikidata.org/entity/Q33811339

description

2010 nî lūn-bûn

@nan

2010 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

An international survey of phy ...... sease morbidity and mortality.

@ast

An international survey of phy ...... sease morbidity and mortality.

@en

type

label

An international survey of phy ...... sease morbidity and mortality.

@ast

An international survey of phy ...... sease morbidity and mortality.

@en

prefLabel

An international survey of phy ...... sease morbidity and mortality.

@ast

An international survey of phy ...... sease morbidity and mortality.

@en

P1433

Q33811339-E93C9CC3-00B3-440A-BEF9-4E323906DF78

P1476

Q33811339-C28103F0-D59C-4619-9237-5D63E20154D4

P2093

Q33811339-0BF73905-4772-455F-A6BD-896F27065621

Q33811339-1266BF45-1B10-4A39-A265-DEE19877D0D1

Q33811339-51680180-DE44-4918-846C-69C9B695BD09

Q33811339-7A05B840-AB93-4A69-858F-E666730BEE45

Q33811339-B7B8D5F6-769E-43A2-891C-B644798EF0FC

Q33811339-C553D6E9-1475-489B-9265-3486F0D237A9

Q33811339-CF413648-96E8-4594-B7BC-DFDBFEBC2300

Q33811339-F7701D66-C520-4FEB-9AED-D861F9CB7A9C

Q33811339-FC5010C2-C610-4BD1-8C3D-D019A643DF3B

P2860

Q33811339-11719161-539C-4BA4-8750-4683BC6FAEA2

Q33811339-12422F91-0624-4BB4-BE9B-C28AB9A4C011

Q33811339-21FC6427-161E-4394-B30D-0DE7B79D2655

Q33811339-25E0AA4E-73C4-4BB1-923D-C57409F4D54C

Q33811339-2ABA1DD1-6DAC-4A3D-97EE-2536355DBBAE

Q33811339-31E96E05-7AD9-42C3-9901-B8298B29A6E3

Q33811339-34AA5DC1-DFDF-4EDA-8A26-C2BF66B44E06

Q33811339-367D1C0B-2D8A-4063-B853-0F2E856A5D49

Q33811339-4A155F7C-0272-4BCB-8EAB-7C26794C2683

Q33811339-5A391D5E-A8E5-4800-A89B-C6529B8CF9E4

P304

Q33811339-0A0C8A40-9A24-4643-945C-40109F23A927

P31

Q33811339-FB31E724-539C-429A-B02A-86DEEF0299B9

P356

Q33811339-06A6C004-3F81-4BAF-8586-9A2C81A9FE96

P433

Q33811339-D1C939E5-A07A-4421-AA57-549799F9038F

P478

Q33811339-B4188BEB-3EB7-4813-8102-81655AFC2F44

P50

Q33811339-17E1FC0E-2CE7-4878-8A7D-E44EF6276B2C

Q33811339-547313E2-8FD2-43E2-BDA6-898A6C7E607E

Q33811339-E1471978-DC8A-4D9A-8C67-E1F0F8F7A35D

P577

Q33811339-DDFC265A-62D4-4E75-8CBF-E92B11D0A253

P5875

Q33811339-9EBAF0D0-5347-4BE0-AA6E-59DEDC8315E7

P698

Q33811339-76598AAC-62D1-418E-BA50-AEC5024B9266

P921

Q33811339-1E61FE6E-166E-4A42-8E14-C6DF3B4A1A0D

Q33811339-9510EB6D-27F2-4CE1-9806-12C83BFBAE3B

Q33811339-A76E02A4-220D-43F1-A8F6-40773683D839

P932

Q33811339-6A69255B-7C3F-4AA5-87DC-7AA83B80DC35

P356

P1433

P1476

An international survey of phy ...... sease morbidity and mortality.

@en

P2093

Atrial Fibrillation AWareness And Risk Education group

http://www.w3.org/2001/XMLSchema#string

Atrial Fibrillation Association

http://www.w3.org/2001/XMLSchema#string

Etienne Aliot

http://www.w3.org/2001/XMLSchema#string

John Camm

http://www.w3.org/2001/XMLSchema#string

Josep Brugada

http://www.w3.org/2001/XMLSchema#string

Markus Wagner

http://www.w3.org/2001/XMLSchema#string

Panos E Vardas

http://www.w3.org/2001/XMLSchema#string

Stroke Alliance for Europe

http://www.w3.org/2001/XMLSchema#string

World Heart Federation

http://www.w3.org/2001/XMLSchema#string

P2860

ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation

Doctors' beliefs on the use of antithrombotic therapy in atrial fibrillation: identifying barriers to stroke prevention

A national survey of the prevalence, incidence, primary care burden and treatment of atrial fibrillation in Scotland

Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study

Atrial fibrillation as an independent risk factor for stroke: the Framingham Study

Incidence and prognostic significance of atrial fibrillation in acute myocardial infarction: the GISSI-3 data.

A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study.

Quality of life in patients with atrial fibrillation: a systematic review.

Atrial fibrillation is associated with severe acute ischemic stroke.

Lifetime risk for development of atrial fibrillation: the Framingham Heart Study.

P304

626-633

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/EUROPACE/EUQ109

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

Gregory Y. H. Lip

Günter Breithardt

European Heart Rhythm Association

P577

2010-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

43345450

http://www.w3.org/2001/XMLSchema#string

P698

20421224

http://www.w3.org/2001/XMLSchema#string

P921

Aparato circulatorio

atrial fibrillation

P932

2859877

http://www.w3.org/2001/XMLSchema#string